Sanofi To Invest $1.05 Bln For New Insulin Production Base In Chinafxcue.com

(fxcue news) - French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in Beijing, China, reports said. The move represents Sanofi's single largest investment in China so far, where it has been present for more than 40 years. The investment will boost the manufacturing of insulin to help diabetic patients in the region and enhance the company's supply-chain resilience. The new site, located in an economic development zone in Yizhuang, will be Sanofi's second production base in Beijing and its fourth in the country. Sanofi signed a memorandum of cooperation with the Beijing Municipal Bureau of Economy and Information Technology and the Beijing Economic-Technological Development Area or BDA Administrative Committee regarding the investment. According to Sanofi Chief Executive Paul Hudson, the new production base will feature advanced automated production technologies, cutting-edge digital integrated management systems and sustainable environmental standards. Medical journal the Lancet reportedly pointed that China now has the largest number of diabetes patients worldwide.

Sanofi To Invest $1.05 Bln For New Insulin Production Base In China

Australian Market Significantly Higher

Bay Street Likely To Open On Mixed Note

Pound Falls Against Majors

Euro Falls Amid French Political Uncertainty

Australia Has A$14.149 Billion Current Account Deficit

Indonesia Stock Market May Find Traction On Tuesday

Sanofi To Invest $1.05 Bln For New Insulin Production Base In China

China Stock Market May Add To Its Winnings On Tuesday

Please sign in

Trader

Buy more spot gold for profit and take profit

Spot gold operation strategy: 1. Gold rebounds 2638-2642, sell empty, stop loss 2651, target line 2588-2593; 2. Gold retraces to buy long at 2586-2593, stop loss at 2575, target at 2630-35 line;

Spot gold 2630 short, target 2618, stop loss 2635. Buy long at 2618-20, stop loss at 2612, target at 2630-40.

Buy long near the current gold price of 2622, with targets of 2633, 2642, and 2650; If three points of 2642, 2650, and 2664 are given for the first time, short selling is allowed; If you buy more in batches around three o'clock on 2619, 2616, and 2610;

Buy more near the opening of gold at around 2606, lose 2598, look at 2620, 2626; Short selling is available near 2647 first!

Gold trading: 2615 short selling, loss 2624, take profit 2593

Tags

Sanofi To Invest $1.05 Bln For New Insulin Production Base In China

Australian Market Significantly Higher

Bay Street Likely To Open On Mixed Note

Pound Falls Against Majors

Euro Falls Amid French Political Uncertainty

Australia Has A$14.149 Billion Current Account Deficit

Indonesia Stock Market May Find Traction On Tuesday

Sanofi To Invest $1.05 Bln For New Insulin Production Base In China

China Stock Market May Add To Its Winnings On Tuesday

Please sign in

Trader

Buy more spot gold for profit and take profit

Spot gold operation strategy: 1. Gold rebounds 2638-2642, sell empty, stop loss 2651, target line 2588-2593; 2. Gold retraces to buy long at 2586-2593, stop loss at 2575, target at 2630-35 line;

Spot gold 2630 short, target 2618, stop loss 2635. Buy long at 2618-20, stop loss at 2612, target at 2630-40.

Buy long near the current gold price of 2622, with targets of 2633, 2642, and 2650; If three points of 2642, 2650, and 2664 are given for the first time, short selling is allowed; If you buy more in batches around three o'clock on 2619, 2616, and 2610;

Buy more near the opening of gold at around 2606, lose 2598, look at 2620, 2626; Short selling is available near 2647 first!

Gold trading: 2615 short selling, loss 2624, take profit 2593

Tags

关注我们的公众号